The effect of AZD9567 vs. prednisolone on glycaemic control in patients with type 2 diabetes mellitus: Results from a phase 2a clinical trial.
Philip AmberyGrzegorz ZajacJoachim AlmquistSusanne ProthonCarol AstburyMary N BrownSzilárd NemesJoselyne NsabimanaKarl EdmanLisa ÖbergMatti LepistöGoran EdenroInken DillmannSuman MitraGraham BelfieldChristina KeenTim HeisePublished in: British journal of clinical pharmacology (2024)
AZD9567 significantly reduced treatment-induced hyperglycaemia compared with prednisolone.